SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-20-000250
Filing Date
2020-01-03
Accepted
2020-01-03 18:08:37
Documents
2
Period of Report
2020-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 6919
2 EXHIBIT 24 ex24.htm EX-24 3373
  Complete submission text file 0001140361-20-000250.txt   12446
Mailing Address 9 WEST 57TH STREET 41ST FLOOR NEW YORK NY 10019
Business Address 9 WEST 57TH STREET 41ST FLOOR NEW YORK NY 10019 212-230-9742
KKR Management Holdings Corp (Reporting) CIK: 0001472692 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 20507278

Mailing Address 9 WEST 57TH STREET 41ST FLOOR NEW YORK NY 10019
Business Address 9 WEST 57TH STREET 41ST FLOOR NEW YORK NY 10019 212-230-9742
KKR Management Holdings L.P. (Reporting) CIK: 0001472693 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 20507277

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations